Participants
The flowchart of the participants is shown in Figure 1. Consent was obtained from 62 individuals, of whom 17 were excluded from the analysis for the following reasons: five withdrew consent, six had changes in treatment plans, five could not follow the protocol due to changes in surgical schedules, and one was found to have multiple cancers. In total, 45 patients were included in the analysis, with 27 and 18 in the control and intervention groups, respectively. The average age was 80.4 years, and 37.8% of the participants were male. Survival data were available for all participants at the one-year follow-up; however, one participant from each group could not be evaluated by the assessors. The postoperative diagnoses included esophageal, gastric, gastrointestinal stromal, duodenal, liver, metastatic liver, bile duct, pancreatic, colon, and cecal cancers. No adverse or side effects related to the intervention were reported.
Baseline Characteristics
The baseline characteristics are shown in Table 1. No significant differences were observed in age, sex, and body mass index (BMI) between the control and intervention groups. The types of cancer, clinical stages of cancer, surgical methods, and performance statuses were also similar between the two groups. There were no significant differences in components of the CGA, including the Barthel Index, Lawton's IADL, MMSE, Vitality Index, GDS-15, and Apathy Scale. The results of physical function evaluations, including grip strength, isometric knee extension strength, walking speed, and SMI, also showed no significant differences. The serological evaluation revealed no significant differences in hemoglobin, serum albumin, serum creatinine, and serum C-reactive protein values between the two groups.
Table 1. Baseline characteristics
Variable
|
Control Group (n=27)
|
Intervention Group (n=18)
|
P-value
|
Age (years)
|
80.6 ± 5.4
|
80.0 ± 3.4
|
0.68
|
Sex (male, n %)
|
9 (33.3%)
|
8 (44.4%)
|
0.54
|
BMI (kg/m²)
|
22.0 ± 3.3
|
21.6 ± 5.3
|
0.78
|
Cancer Type (%)
|
|
|
0.27
|
- Upper gastrointestinal
|
6 (22.2%)
|
3 (16.7%)
|
|
- Hepatobiliary pancreas
|
8 (29.6%)
|
10 (55.6%)
|
|
- Lower gastrointestinal
|
13 (48.1%)
|
5 (27.8%)
|
|
Clinical Stage (%)
|
|
|
0.47
|
- 0-1
|
10 (37.0%)
|
6 (33.3%)
|
|
- 2
|
10 (37.0%)
|
7 (38.9%)
|
|
- 3
|
4 (14.8%)
|
2 (11.1%)
|
|
- 4
|
3 (11.1%)
|
3 (16.7%)
|
|
Surgery Method (%)
|
|
|
0.09
|
- Open surgery
|
7 (25.9%)
|
9 (50.0%)
|
|
- Laparoscopic surgery
|
20 (74.1%)
|
9 (50.0%)
|
|
Preoperative Chemotherapy (yes, %)
|
1 (3.7%)
|
1 (5.6%)
|
1.00
|
Performance Status (%)
|
|
|
1.00
|
- 0
|
23 (85.2%)
|
17 (94.4%)
|
|
- 1
|
2 (7.4%)
|
1 (5.6%)
|
|
- 2
|
1 (3.7%)
|
0 (0.0%)
|
|
- 3
|
1 (3.7%)
|
0 (0.0%)
|
|
Comprehensive Geriatric Assessment
|
|
|
|
- MMSE
|
26.1 ± 2.3
|
25.9 ± 2.1
|
0.82
|
- Barthel index
|
96.9 ± 7.9
|
98.1 ± 3.5
|
0.55
|
- IADL (Lawton's scale)
|
6.2 ± 2.2
|
6.7 ± 1.4
|
0.46
|
- Vitality index
|
9.8 ± 0.7
|
10.0 ± 0.0
|
0.26
|
- GDS-15
|
2.7 ± 3.0
|
3.2 ± 2.7
|
0.63
|
- Apathy scale
|
10.7 ± 6.1
|
9.9 ± 5.6
|
0.66
|
Total Number of Medications
|
6.1 ± 2.9
|
4.9 ± 2.8
|
0.18
|
Grip Strength (kg) Men
|
21.9 ± 4.3
|
24.5 ± 5.6
|
0.29
|
Grip Strength (kg) Women
|
15.8 ± 1.9
|
15.5 ± 3.2
|
0.74
|
Isometric Knee Extension Strength (kg)
|
|
|
|
- Men
|
21.8 ± 7.0
|
25.5 ± 7.3
|
0.30
|
- Women
|
17.0 ± 4.6
|
14.7 ± 5.7
|
0.24
|
Walking Speed (m/s)
|
1.1 ± 0.2
|
1.0 ± 0.3
|
0.72
|
SMI (kg/m²) Men
|
7.2 ± 1.0
|
6.8 ± 1.2
|
0.43
|
SMI (kg/m²) Women
|
6.0 ± 0.6
|
6.0 ± 1.0
|
0.96
|
J-CHS Criteria Frailty
|
|
|
0.76
|
- Prefrail
|
14 (51.9%)
|
11 (61.1%)
|
|
- Frail
|
13 (48.1%)
|
7 (38.9%)
|
|
Hemoglobin (g/dL)
|
11.6 ± 2.2
|
12.7 ± 1.9
|
0.11
|
Serum Albumin (g/dL)
|
3.8 ± 0.4
|
3.9 ± 0.4
|
0.57
|
Serum Creatinine (mg/dL)
|
0.86 ± 0.26
|
0.81 ± 0.31
|
0.55
|
CRP (mg/dL)
|
0.84 ± 2.4
|
0.94 ± 1.47
|
0.87
|
Baseline characteristics of participants in the control and intervention groups. Continuous variables are expressed as mean ± SD and were compared using Student's t-test. Categorical variables are expressed as counts and percentages and were compared using Fisher's exact test. P-values indicate statistical significance between groups.
BMI: body mass index; SMI: skeletal muscle mass index; CRP: C-reactive protein. IADL: Lawton's Instrumental Activities of Daily Living; MMSE: Mini Mental Status examination; GDS-15, Geriatric Depression Scale-15; J-CHS, the Japanese version of the Cardiovascular Health Study.
[Table 1 here]
Adherence to Exercise
The rates of adherence to exercise are shown in Table 2. The compliance rate for wearing the activity tracker was 98.0% and 96.4% in the control and intervention groups, respectively, with participants wearing the activity tracker for nearly the entire two-week pre-surgery period (p=0.45). Only participants in the intervention group performed resistance training, with an average rate of adherence to exercise of 85.2%.
Table 2. Adherence to exercise and physical activity in the control and intervention groups
Variable
|
Control Group (n=27)
|
Intervention Group (n=18)
|
P-value
|
Activity Tracker Compliance (%)
|
98.0 ± 6.1
|
96.4 ± 7.9
|
0.45
|
Exercise Adherence Rate (%)
|
N/A
|
85.2 ± 20.0
|
N/A
|
Daily Steps (steps/day)
|
4045.9 ± 2161.6
|
3816.9 ± 2142.2
|
0.73
|
Total Daily Energy Expenditure (kcal/day)
|
1511.7 ± 250.0
|
1491.7 ± 226.0
|
0.79
|
Continuous variables are presented as mean ± SD and were compared using Student's t-test. P-values indicate statistical significance between groups. N/A: Not Applicable. Data are not available for the control group as the exercise was not performed by this group.
Postoperative Complications
The incidence of postoperative complications is shown in Table 3. Overall postoperative complications, the primary endpoint, were observed in 48.1% and 44.4% of the control and intervention groups, respectively (relative risk (RR) 0.92, 95% confidence interval (CI) 0.57–2.07). Postoperative delirium occurred in 25.9% and 33.3% of the control and intervention groups, respectively (RR 1.29, 95% CI 0.31–1.94). No statistically significant differences were observed between the groups.
Table 3. Incidence of postoperative complications and one-year follow-up results in frail cancer patients
Variable
|
Control Group (n=27)
|
Intervention Group (n=18)
|
95% CI
|
Postoperative Complications (%)
|
13 (48.1%)
|
8 (44.4%)
|
0.57–2.07
|
Postoperative Delirium (%)
|
7 (25.9%)
|
6 (33.3%)
|
0.31–1.94
|
One-Year Follow-Up Results:
|
|
|
|
Death
|
4 (14.8%)
|
1 (5.6%)
|
0.01–3.92
|
Decreased ADL or Death
|
11 (42.3%)
|
4 (23.5%)
|
0.08–1.92
|
Postoperative complications and delirium are presented as counts and percentages. One-year follow-up results, including death and decreased activities of daily living (ADL), are also shown. In the intervention group, the evaluation of ADL was not available in one participant. The 95% confidence interval (95% CI) was provided for comparison between the groups.
Changes in Physical Function
The changes in physical function over time are shown in Figure 2. Grip strength was almost identical between the two groups at all three time points, with differences of less than 1% (preoperatively: 99.5±8.9% vs 100.1±19.2%, p=0.88; discharge: 96.0±9.0% vs 97.5±14.5%, p=0.70). Knee extension strength increased to 119.1% preoperatively in the intervention group; however, no significant difference was observed between the groups. Knee extension strength decreased to 86.7% in the control group but was maintained at 119.3% in the intervention group at discharge, with a significant difference between the groups (preoperatively: 100.2±18.3% vs 119.1±68.8%, p=0.19; discharge: 86.7±22.0% vs 119.3±72.0%, p=0.044). Walking speed and SMI showed similar trends, with a decrease in the control group at discharge; however, the difference between the groups was not significant (walking speed: preoperatively: 98.1±25.9% vs 115.7±60.5%, p=0.16; discharge: 80.0±22.4% vs 92.5±50.0%, p=0.29; SMI: preoperatively: 99.8±7.1% vs 101.3±5.1%, p=0.45; discharge: 91.9±8.8% vs 95.1±11.4%, p=0.34).
One-Year Follow-Up
The results of the one-year follow-up survey are presented in Table 3. Overall, 14.8% of participants in the control group and 5.6% in the intervention group died during the one-year follow-up period (RR 0.38, 95% CI 0.01–3.92). The proportion of patients with decreased ADL or death was lower in the intervention group than in the control group; however, the difference was not statistically significant (42.3% in the control group vs 23.5% in the intervention group; RR 0.56, 95% CI 0.08–1.92).